The impact of insolvency on licensors and licensees in the life sciences sector
At a time when well-known names are disappearing from the high street as a result of retailers going into administration, the spectre of corporate insolvencies has never loomed larger. The life sciences sector is feeling the pressure for a number of well-documented reasons — a difficult funding environment, a challenging regulatory landscape and dwindling pipelines — and these all, sadly, mean that insolvencies in the sector are happening and will continue to happen. So it is prudent for any life sciences company to consider the potential impact of the insolvency of its counterparty in each agreement that it enters into. This article considers in particular the impact on intellectual property (IP) licences.
What is insolvency? In the UK, a company can become ‘cash flow insolvent’, meaning it is unable to pay its debts as they fall due, or ‘balance sheet insolvent’, where its liabilities exceed its assets.
What are the main insolvency procedures? The Insolvency Act 1986, as amended, along with the Companies Act 2006, provides a comprehensive toolbox of different procedures that creditors and debtors may take advantage of…
Click on the link below to read the rest of the Taylor Wessing briefing.
News from Taylor Wessing
News from The Lawyer
Briefings from Taylor Wessing
For the tax year from 6 April 2014, the standard lifetime allowance has reduced from £1.5m to £1.25m.
One of the areas highlighted last year by the Regulator was the regulation of workplace DC pension schemes.
Analysis from The Lawyer
As the equity capital markets rocketed back into favour and global M&A saw at least a partial return to form, there have been some rich pickings for The Lawyer’s Corporate Team of the Year award shortlisted firms in 2014.
The city-state is working hard to become a global wealth management hub, and law firms are gearing up for a prosperous new world